Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell-like [ABC], germinal-center B-cell-like [GCB], and unclassified) according to cell of origin that are associated with a differential response to chemotherapy and targeted agents. We sought to extend these findings by identifying genetic subtypes of DLBCL based on shared genomic abnormalities and to uncover therapeutic vulnerabilities based on tumor genetics. METHODS: We studied 574 DLBCL biopsy samples using exome and transcriptome sequencing, array-based DNA copy-number analysis, and targeted amplicon resequencing of 372 genes to identify genes with recurrent aberrations. We developed and implemented an algorithm to discover genetic subtypes based on the co-occurrence of genetic alterations. RESULTS: and CD79B mutations), BN2 (based on BCL6 fusions and NOTCH2 mutations), N1 (based on NOTCH1 mutations), and EZB (based on EZH2 mutations and BCL2 translocations). Genetic aberrations in multiple genes distinguished each genetic subtype from other DLBCLs. These subtypes differed phenotypically, as judged by differences in gene-expression signatures and responses to immunochemotherapy, with favorable survival in the BN2 and EZB subtypes and inferior outcomes in the MCD and N1 subtypes. Analysis of genetic pathways suggested that MCD and BN2 DLBCLs rely on "chronic active" B-cell receptor signaling that is amenable to therapeutic inhibition. CONCLUSIONS: We uncovered genetic subtypes of DLBCL with distinct genotypic, epigenetic, and clinical characteristics, providing a potential nosology for precision-medicine strategies in DLBCL. (Funded by the Intramural Research Program of the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“LBCL is genetically and biologically heterogeneous. This diversity includes both tumor and the corresponding tumor microenvironment (TME), and it affects response to standard immunochemotherapy.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationStromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationChronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Self-citationOncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Self-citationTargeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationA loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
Self-citationExploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
Self-citationInhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Lionakis, M. S., Dunleavy, K., Roschewski, M., Widemann, B. C., Butman, J. A., Schmitz, R., Yang, Y., Cole, D. E., Melani, C., Higham, C. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.012 · Cited by 508
Self-citationChalla-Malladi, M., Lieu, Y. K., Califano, O., Holmes, A. B., Bhagat, G., Murty, V. V., Dominguez-Sola, D., Pasqualucci, L., & Dalla-Favera, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.006 · Cited by 439
Cited by
Items 601–700 of 1,000
Pan, T., He, Y., Chen, H., Pei, J., Li, Y., Zeng, R., Xia, J., Zuo, Y., Qin, L., Chen, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.614211 · Cited by 23
An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach
Yanguas‐Casás, N., Pedrosa, L., Fernández‐Miranda, I., & Sánchez‐Beato, M. (2021) · Cancers · doi:10.3390/cancers13122893 · Cited by 23
Biology of Germinal Center B Cells Relating to Lymphomagenesis
Basso, K. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000582 · Cited by 23
Santiago, R., Jiménez, J. O., Forghani, R., Muthukrishnan, N., Corpo, O. D., Karthigesu, S., Haider, M. Y., Reinhold, C., & Assouline, S. E. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101188 · Cited by 23
Durmaz, M., Visser, O. J., Posthuma, E. F. M., Brouwer, R. E., Issa, D. E., de Jong, D., Lam, K. H., Blijlevens, N. M. A., Zijlstra, J. M., Chamuleau, M. E. D., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00637-1 · Cited by 23
Kuker, R. A., Lehmkuhl, D., Kwon, D., Zhao, W., Lossos, I. S., Moskowitz, C. H., Alderuccio, J. P., & Yang, F. (2022) · Cancers · doi:10.3390/cancers14215221 · Cited by 23
Drug addiction unveils a repressive methylation ceiling in EZH2-mutant lymphoma
Kwok, H. S., Freedy, A. M., Siegenfeld, A. P., Morriss, J. W., Waterbury, A. L., Kissler, S. M., & Liau, B. B. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01299-1 · Cited by 23
Zhu, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-33585-2 · Cited by 23
Maestre, L., García, J. F., Jiménez, S., Reyes-García, A. I., García-González, Á., Montes‐Moreno, S., Arribas, A. J., González‐García, P., Caleiras, E. J., Banham, A. H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229743 · Cited by 23
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
Lampson, B. L., Gupta, A., Tyekucheva, S., Mashima, K., Petráčková, A., Wang, Z., Wojciechowska, N., Shaughnessy, C. J., Baker, P. O., Fernandes, S. M., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.00269 · Cited by 22
Vogt, J. A., Wagener, R., Montesinos‐Rongen, M., Ammerpohl, O., Paulus, W., Deckert, M., & Siebert, R. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22687 · Cited by 22
Burkhard, R., Keller, I., Arambasic, M., Juškevičius, D., Tzankov, A., Lundberg, P., Bruggmann, R., Dirnhofer, S., Radpour, R., & Novak, U. (2018) · Haematologica · doi:10.3324/haematol.2018.201590 · Cited by 22
Nowicka, M., Hilton, L. K., Ashton‐Key, M., Hargreaves, C. E., Lee, C. S., Foxall, R. B., Carter, M. J., Beers, S. A., Potter, K. N., Bolen, C. R., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004770 · Cited by 22
Precision diagnostics in lymphomas – Recent developments and future directions
Mansouri, L., Þorvaldsdóttir, B., Laidou, S., Σταματόπουλος, Κ., & Rosenquist, R. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.007 · Cited by 22
Flümann, R., Hansen, J., Pelzer, B. W., Nieper, P., Lohmann, T., Kisis, I., Riët, T., Kohlhas, V., Nguyen, P., Peifer, M., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0007 · Cited by 22
Isaksen, K. T., Galleberg, R., Mastroianni, M. A., Rinde, M., Rusten, L. S., Barzenje, D. A., Ramslien, L. F., Fluge, Ø., Slaaen, M., Meyer, P., et al. (2023) · Haematologica · doi:10.3324/haematol.2022.282289 · Cited by 22
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
Mozas, P., López, C., Grau, M., Nadeu, F., Clot, G., Valle, S., Kulis, M., Navarro, A., Ramis-Zaldivar, J. E., González‐Farré, B., et al. (2023) · Hematological Oncology · doi:10.1002/hon.3132 · Cited by 22
Self-citationGarcia-Lacarte, M., Grijalba, S. C., Melchor, J., Pascual, M., Goñi, E., Clemente‐Larramendi, I., Morales-Sánchez, S., Burrell, M. A., Blanco, Ó., Arnaiz-Leché, A., et al. (2025) · Blood · doi:10.1182/blood.2024025755 · Cited by 22
Sönmez, E. E., & Küçük, C. (2019) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1908-23 · Cited by 22
Sarbazi-Azad, S., Abadeh, M. S., & Mowlaei, M. E. (2020) · Soft Computing Letters · doi:10.1016/j.socl.2020.100007 · Cited by 22
Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
Pileri, S. A., Tripodo, C., Melle, F., Motta, G., Tabanelli, V., Fiori, S., Vegliante, M. C., Mazzara, S., Ciavarella, S., & Derenzini, E. (2021) · Cells · doi:10.3390/cells10030675 · Cited by 22
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma
Seshadri, M. R., & Melnick, A. M. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1999444 · Cited by 22
Kostakoğlu, L., Dalmasso, F., Berchialla, P., Pierce, L. A., Vitolo, U., Martelli, M., Sehn, L. H., Trněný, M., Nielsen, T. G., Bolen, C. R., et al. (2022) · eJHaem · doi:10.1002/jha2.421 · Cited by 22
Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma
Yan, J., Yuan, W., Zhang, J., Li, L., Zhang, L., Zhang, X., & Zhang, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.846357 · Cited by 22
Melnik, B. C., Stadler, R., Weiskirchen, R., Leitzmann, C., & Schmitz, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076102 · Cited by 22
Du, K., Wu, Y., Wei, H., Duan, Z., Gao, R., Liang, J., Li, Y., Yin, H., Wu, J., Shen, H.-R., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01765-w · Cited by 21
Self-citationXu, Q., Ma, L., Streuer, A., Altrock, E., Schmitt, N., Rapp, F., Klär, A., Nowak, V., Obländer, J., Weimer, N., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02176-1 · Cited by 22
Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2
Liu, X., Zeng, L., Liu, J., Huang, Y., Yao, H., Zhong, J., Tan, J., Gao, X., Xiong, D., & Liu, L. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07822-7 · Cited by 21
Self-citationDiffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk
Duminuco, A., Scarso, S., Fabro, V. D., Caruso, L. A., Stanzione, G., Raimondo, F. D., Palumbo, G. A., & Vetro, C. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06686-3 · Cited by 21
Genomic Landscape of Waldenström Macroglobulinemia
Treon, S. P., Xu, L., Liu, X., Hunter, Z. R., Yang, G., & Castillo, J. J. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.05.003 · Cited by 21
Self-citationKizhakeyil, A., Zaini, N. B. M., Poh, Z. S., Wong, B. H. S., Loh, X., Ng, A. S., Low, Z. S., Prasannan, P., Gong, C., Tan, M. G. K., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01437-0 · Cited by 21
Self-citationZhang, H., Lu, Y., Zhang, T., Guan, Q., Wang, X., Guo, Y., Li, L., Qiu, L., Qian, Z., Zhou, S., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.808 · Cited by 21
Shi, H., Zheng, P., Liu, R., Xu, T., Yang, F., Feng, S., Guo, Y., Ma, L., Liu, H., Yang, L., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006845 · Cited by 21
Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside
Deng, X., Zhang, M., Zhou, J., & Xiao, M. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00300-2 · Cited by 21
Molecular Monitoring of Lymphomas
Schroers‐Martin, J. G., Alig, S., Garofalo, A., Tessoulin, B., Sugio, T., & Alizadeh, A. A. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-050520-044652 · Cited by 21
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction
Ceccato, J., Piazza, M., Pizzi, M., Manni, S., Piazza, F., Caputo, I., Cinetto, F., Pisoni, L., Trojan, D., Scarpa, R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947823 · Cited by 21
The dual role of CD70 in B‐cell lymphomagenesis
Nie, M., Ren, W., Ye, X., Berglund, M., Wang, X., Fjordén, K., Du, L., Giannoula, Y., Lei, D., Su, W., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1118 · Cited by 21
The roles of KLHL family members in human cancers.
Ye, G., Wang, J., Yang, W., Li, J., Meng, Y., & Jin, X. (2022) · PubMed Central · Cited by 21
Self-citationJin, Z., Xiang, R., Qing, K., Li, D., Liu, Z., Li, X., Zhu, H., Zhang, Y., Wang, L., Xue, K., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00833-6 · Cited by 21
CellSTAR: a comprehensive resource for single-cell transcriptomic annotation
Zhang, Y., Sun, H., Zhang, W., Fu, T., Huang, S., Mou, M., Zhang, J., Gao, J., Ge, Y., Yang, Q., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad874 · Cited by 21
Kwak, J. J., Lee, K. S., Lee, J., Kim, Y. J., Choi, E. Y., Byeon, S. H., Chang, W. S., Kim, Y. R., Kim, J. S., Shin, S., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.14.27 · Cited by 21
Ding, M., Yu, Z., Lu, T., Hu, S., Zhou, X., & Wang, X. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1747 · Cited by 21
Optimizing initial therapy in DLBCL
Thiéblemont, C., Bernard, S., Meignan, M. A., & Molina, T. J. (2018) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2018.08.001 · Cited by 21
Cui, Q., Vari, F., Cristino, A. S., Salomón, C., Rice, G. E., Sabdia, M. B., Guanzon, D., Palma, C., Mathew, M., Talaulikar, D., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26141 · Cited by 21
Lymphoma of the female genital tract: a clinicopatholngical analysis of 25 cases.
Wang, J., Zeng, L., Chen, S., Wu, Q., Ma, L., Wu, S., Wang, Z. P., Tao, Y., & Chai, D. (2019) · PubMed · Cited by 21
Self-citationCirculating tumour DNA in B‐cell lymphomas: current state and future prospects
Lakhotia, R., & Roschewski, M. J. (2021) · British Journal of Haematology · doi:10.1111/bjh.17251 · Cited by 21
Genomic characterisation of diffuse large B-cell lymphoma
Harrington, F., Greenslade, M., Talaulikar, D., & Corboy, G. (2021) · Pathology · doi:10.1016/j.pathol.2020.12.003 · Cited by 21
Zhou, Z., Zhang, L., Wang, X., Li, X., Li, L., Fu, X., Zhang, X., Li, Z., Sun, Z., & Zhang, M. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04535-7 · Cited by 21
Mishina, T., Oshima‐Hasegawa, N., Tsukamoto, S., Fukuyo, M., Kageyama, H., Muto, T., Mimura, N., Rahmutulla, B., Nagai, Y., Kayamori, K., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17765 · Cited by 21
Schrader, A. M. R., de Groen, R. A. L., Willemze, R., Jansen, P. M., Quint, K. D., van Wezel, T., van Eijk, R., Ruano, D., Tensen, C. P., Hauben, E. I., et al. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03265-5 · Cited by 21
Daneels, W., Rosskamp, M., Macq, G., Saadoon, E. I., Geyndt, A. D., Offner, F. C., & Poirel, H. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.824704 · Cited by 21
Genomics of aggressive B-cell lymphoma
Rosenthal, A. C., & Rimsza, L. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.69 · Cited by 21
Self-citationVannata, B., Conconi, A., Winkler, J., Cascione, L., Casaluci, G. M., Nassi, L., Moia, R., Pirosa, M. C., Moccia, A. A., Stathis, A., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16106 · Cited by 21
Risueño, A., Hagner, P. R., Towfic, F., Fontanillo, C., Djebbari, A., Parker, J. S., Drew, C. P., Nowakowski, G. S., Maurer, M. J., Cerhan, J. R., et al. (2020) · Blood · doi:10.1182/blood.2019002414 · Cited by 21
Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen
Mo, Z., Wood, S., Namiranian, S., Mizukoshi, R., Weng, S., Jang, I. S., Fontanillo, C., Baughman, J. M., Silva-Torres, A., Slade, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003431 · Cited by 21
Blansky, D., Fazzari, M. J., Mantzaris, I., Rohan, T. E., & Hosgood, H. D. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1839656 · Cited by 20
Pan, M., Yang, P., Wang, F., Luo, X., Li, B., Ding, Y., Lu, H., Dong, Y., Zhang, W., Xiu, B., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.648800 · Cited by 20
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
Faumont, N., Taoui, O., Collares, D., Jaïs, J., Leroy, K., Prévaud, L., Jardin, F., Molina, T. J., Copie‐Bergman, C., Petit, B., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638897 · Cited by 20
Bouroumeau, A., Bussot, L., Bonnefoix, T., Fournier, C., Chapusot, C., Casasnovas, O., Martin, L., Leer, A. M., Col, E., David‐Boudet, L., et al. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.223 · Cited by 20
Sequencing therapy in relapsed DLBCL
Flowers, C. R., & Odejide, O. O. (2022) · Hematology · doi:10.1182/hematology.2022000332 · Cited by 20
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
Chan, J. Y., Somasundaram, N., Grigoropoulos, N. F., Lim, F., Poon, M., Jeyasekharan, A. D. D., Yeoh, K. W., Tan, D. C. L., Lenz, G., Ong, C. K., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00754-8 · Cited by 20
Salwa, A., Ferraresi, A., Secomandi, E., Vallino, L., Moia, R., Patriarca, A., Garavaglia, B., Gaïdano, G., & Isidoro, C. (2023) · Cells · doi:10.3390/cells12151924 · Cited by 20
Deng, T., Zhang, S., Xiao, M., Gu, J., Huang, L., & Zhou, X. (2024) · Cancer Medicine · doi:10.1002/cam4.7005 · Cited by 20
Koumpis, E., Papoudou‐Bai, A., Papathanasiou, K., Kolettas, E., Kanavaros, P., & Hatzimichael, E. C. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070420 · Cited by 20
Robetorye, R. S., Ramsower, C. A., Rosenthal, A. C., Yip, T., Spiczka, A. W., Glinsmann‐Gibson, B., & Rimsza, L. M. (2019) · Journal of Hematopathology · doi:10.1007/s12308-019-00344-0 · Cited by 20
Self-citationIndications of next-generation sequencing in non-Hodgkin's lymphoma
Heimann, P., & Dewispelaere, L. (2020) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000666 · Cited by 21
Orgueira, A. M., Arias, J. Á. D., López, M. C., Raíndo, A. P., Rodríguez, B. A., Santos, C. A., Vence, N. A., López, Á. B., Blanco, A. A., Pérez, L. B., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07492-y · Cited by 20
GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas
Marcus, C. B., Maragkos, G. Α., Alterman, R. L., Uhlmann, E. J., Pihan, G. A., & Varma, H. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.11.031 · Cited by 20
Cheng, Q., Wang, J., Lv, C., & Xu, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s309408 · Cited by 20
Self-citationLópez-Santillán, M., López-López, E., Alvarez-Gonzalez, P., Martínez, G., Arzuaga‐Méndez, J., Ruiz-Díaz, I., Guerra‐Merino, I., Gutiérrez-Camino, Á., & Martín‐Guerrero, I. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103430 · Cited by 20
International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
Mu, S., Shi, D., Ai, L., Fan, F., Peng, F., Sun, C., & Hu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732006 · Cited by 20
Ren, W., Wang, X., Yang, M., Wan, H., Li, X., Ye, X., Meng, B., Li, W., Yu, J., Lei, M., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006410 · Cited by 20
The Status and Prospects of Epigenetics in the Treatment of Lymphoma
Liu, J., Li, J., Wu, H., & Liu, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.874645 · Cited by 20
Vegliante, M. C., Mazzara, S., Zaccaria, G. M., Summa, S. D., Esposito, F., Melle, F., Motta, G., Sapienza, M. R., Opinto, G., Volpe, G., et al. (2022) · Hematological Oncology · doi:10.1002/hon.3050 · Cited by 20
Self-citationLi, Y., Xu-Monette, Z. Y., Abramson, J. S., Sohani, A. R., Bhagat, G., Tzankov, A., Visco, C., Zhang, S., Dybkær, K., Pan, Z., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008550 · Cited by 20
Improving R-CHOP in diffuse large B-cell lymphoma is still a challenge
Jardin, F. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30021-x · Cited by 20
C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges
Du, H., Gao, L., Luan, J. Y., Zhang, H., & Xiao, T. (2019) · Acta Haematologica · doi:10.1159/000497430 · Cited by 20
A bivalent molecular glue linking lysine acetyltransferases to oncogene-induced cell death
Nix, M. N., Gourisankar, S. P., Bowman, K., Nettles, S. A., Yang, H. H., Dwyer, B. G., Sarott, R. C., Abuzaid, H. Z., Martinez, M. M., Phillips, N. A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.06.037 · Cited by 19
Krupka, J. A., Moutsopoulos, I., Cutmore, N. H., Trethewey, C. S., Dayimu, A., Goodhew, R., Kaji, F. A., Rásó‐Barnett, L., Cheow, H., Elzubeir, L., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-01587 · Cited by 19
Self-citationRichter, J., Hüttmann, A., Rekowski, J., Schmitz, C., Gärtner, S., Rosenwald, A., Hansmann, M., Hartmann, S., Mӧller, P., Wacker, H., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0230-8 · Cited by 19
Self-citationSchrader, A. M. R., de Groen, R. A. L., Willemze, R., Jansen, P. M., Quint, K. D., Cleven, A. H. G., van Wezel, T., van Eijk, R., Ruano, D., Veelken, H., et al. (2022) · Cancers · doi:10.3390/cancers14205152 · Cited by 19
Delage, L., Lambert, M., Bardel, É., Kundlacz, C., Chartoire, D., Conchon, A., Peugnet, A.-L., Gorka, L., Auberger, P., Jacquel, A., et al. (2022) · Blood · doi:10.1182/blood.2022016943 · Cited by 19
Sheng, L., Li, T., Li, Y., Zhou, M., Wang, J., Lai, Y., Zhang, Y., Yi, P., Mu, Q., & Ouyang, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19342 · Cited by 19
Self-citationDiagnostic and prognostic molecular pathology of lymphoid malignancies
Fend, F., van den Brand, M., Groenen, P. J. T. A., Quintanilla‐Martínez, L., & Bagg, A. (2023) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-023-03644-0 · Cited by 19
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL
Eken, J. A., Koning, M. T., Kupcová, K., Sepúlveda-Yáñez, J., de Groen, R. A. L., Quinten, E., Janssen, J., van Bergen, C. A. M., Vermaat, J. S. P., Cleven, A. H. G., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20230941 · Cited by 19
Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside
Almasri, M., Maher, N., Deeban, B. A., Diop, N. M., Moia, R., & Gaïdano, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104869 · Cited by 19
Tang, H., Zhou, H., Wei, J., Liu, H., Qian, W., & Chen, X. (2019) · Hematology · doi:10.1080/16078454.2019.1614289 · Cited by 19
Wang, X., Tan, Y., Huang, Z., Huang, N., Gao, M., Zhou, F., Hu, J., & Feng, W. (2019) · Oncology Reports · doi:10.3892/or.2019.7282 · Cited by 19
Holdhoff, M., Wagner‐Johnston, N. D., & Roschewski, M. J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s192379 · Cited by 19
CD38 expression is an important prognostic marker in diffuse large B‐cell lymphoma
Wada, F., Shimomura, Y., Yabushita, T., Yamashita, D., Ohno, A., Imoto, H., Maruoka, H., Hara, S., & Ishikawa, T. (2021) · Hematological Oncology · doi:10.1002/hon.2904 · Cited by 19
Mouse Models of Germinal Center Derived B-Cell Lymphomas
Meyer, S. N., Koul, S., & Pasqualucci, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710711 · Cited by 19
The biology of the tumor microenvironment in DLBCL: Targeting the “don’t eat me” signal
Ennishi, D. (2021) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.21015 · Cited by 19
Zhou, J., Zuo, M., Li, L., Li, F., Peng, K., Zhou, Y., Xu, Y., Gao, X., Guan, Y., Xia, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.824632 · Cited by 19
Zhu, Y., Lei, C., Jiang, Q., Yu, Q., & Qiu, L. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02661-4 · Cited by 19
Miyawaki, K., & Sugio, T. (2022) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.22027 · Cited by 19
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma
Crombie, J. L., & Armand, P. A. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.03.001 · Cited by 19
Rødland, G. E., Melhus, K. B., Generalov, R., Gilani, S., Bertoni, F., Dahle, J., Syljuåsen, R. G., & Patzke, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01301 · Cited by 19
Thurner, L., Hartmann, S., Bewarder, M., Fadle, N., Regitz, E., Schormann, C., Arauco, N. Q., Kemele, M., Klapper, W., Rosenwald, A., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.241653 · Cited by 19
Self-citationBalasubramanian, S., Wang, S., Major, C. D., Hodkinson, B. P., Schäffer, M., Sehn, L. H., Johnson, P., Zinzani, P. L., Carey, J., Shreeve, S. M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17450 · Cited by 18
Self-citationB Cell Lymphomas of the GI Tract
Small, S. H., Slonim, L. B., Williams, C. J., & Karmali, R. (2021) · Current Gastroenterology Reports · doi:10.1007/s11894-021-00811-8 · Cited by 18
Metadata
- Authors
- Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., Hodson, D. J., Xiao, W., Yu, X., Yang, Y., Zhao, H., Xu, W., Liu, X., Zhou, B., Du, W., Chan, W. C., Jaffe, E. S., Gascoyne, R. D., Connors, J. M., Campo, E., Lopez-Guillermo, A., Rosenwald, A., Ott, G., Delabie, J., Rimsza, L. M., Tay Kuang Wei, K., Zelenetz, A. D., Leonard, J. P., Bartlett, N. L., Tran, B., Shetty, J., Zhao, Y., Soppet, D. R., Pittaluga, S., Wilson, W. H., & Staudt, L. M.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- City Of Hope National Medical Center (US)
- BC Cancer Agency (CA)
- From the Lymphoid Malignancies Branch (R.S., D.W.H., J.D.P., J.Q.W., S.R., M.K., R.M.Y., A.L.S., D.J.H., W. Xiao, X.Y., Y.Y., H.Z., W. Xu, W.H.W., L.M.S.), the Biometric Research Program, Division of Cancer Diagnosis and Treatment (G.W.W.), and the Laboratory of Pathology, Center for Cancer Research (E.S.J., S.P.), National Cancer Institute, and the Office of Intramural Research, Center for Information Technology (C.A.J., X.L., B.Z., W.D.), National Institutes of Health, Bethesda, and the Cancer...
- University of Würzburg (DE)
- Robert Bosch Hospital (DE)
- University Health Network (CA)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- Alliance for Clinical Trials in Oncology (US)
- Washington University in St. Louis (US)
- Frederick National Laboratory for Cancer Research (US)
- ORCID
- Schmitz, Roland
- Wright, George W.
- Huang, Da Wei
- Phelan, James D.
- Wang, James Q.
- Roulland, Sandrine
- Kasbekar, Monica
- Young, Ryan M.
- Shaffer, Arthur L.
- Hodson, Daniel J.
- Xiao, Wenming
- Yu, Xin
- Yang, Yandan
- Zhao, Hong
- Zhou, Bin
- Chan, Wing C.
- Jaffe, Elaine S.
- Gascoyne, Randy D.
- Connors, Joseph M.
- Rosenwald, Andreas
- Ott, German
- Delabie, Jan
- Rimsza, Lisa M.
- Zelenetz, Andrew D.
- Leonard, John P.
- Bartlett, Nancy L.
- Tran, Bao
- Shetty, Jyoti
- Zhao, Yongmei
- Pittaluga, Stefania
- Wilson, Wyndham H.
- Staudt, Louis M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-04-12
- Volume
- 378
- Issue
- 15
- Pages
- 1396-1407
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6010183
- OpenAlex
- W2797584152
- Cited by
- 2,241
- References
- 30
- Citations by year
- 2026: 193 · 2025: 271 · 2024: 320 · 2023: 339 · 2022: 317 · 2021: 302 · 2020: 250 · 2019: 191 · 2018: 53
- FWCI
- 153.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Cancer Institute Strategic Partnering to Evaluate Cancer Signatures (SPECS II) grant (5U01CA157581-05)
- Intramural Research Program of the NIH, National Cancer Institute
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Clinical Neurology › CNS Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- diffuse large B-cell lymphoma, genetic subtypes, B cell receptor signaling, NOTCH1 mutation, NOTCH2 mutation, EZH2 mutation, BCL2 translocation, CD79B mutation, germinal center B-cell-like lymphoma, therapeutic vulnerabilities, precision medicine, survival outcomes
- MeSH terms
- Antineoplastic Combined Chemotherapy Protocols, Biopsy, Genotype, Humans, Mutation, Prognosis, Lymphoma, Large B-Cell, Diffuse, Sequence Analysis, DNA, Genetic Heterogeneity, Gene Expression Profiling, Epigenesis, Genetic, Kaplan-Meier Estimate, Transcriptome, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.